Related Experiment Video
Updated: Aug 7, 2026
14:34
A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
Self-assembled "dock and lock" system for linking payloads to targeting proteins
Marina V Backer1, Vimal Patel, Brian T Jehning
1SibTech, Inc., Newington, Connecticut 06111, USA. mbacker@sibtech.com
Bioconjugate Chemistry
|July 20, 2006
Summary
A novel "dock and lock" protein conjugation system uses human RNase I fragments for stable, functional payload delivery. This self-assembling technology enables targeted therapies and molecular imaging probes.
Area of Science:
- Biotechnology
- Protein Engineering
- Molecular Biology
Background:
- Random conjugation of payloads to targeting proteins leads to heterogeneous products.
- An adapter/docking tag system offers an alternative strategy for controlled conjugation.
- Clinical development requires humanized and circulation-stable adapter/docking tag systems.
Purpose of the Study:
- To develop and characterize a self-assembling, humanized adapter/docking tag system for protein conjugation.
- To demonstrate the system's ability to maintain the function of conjugated proteins.
- To explore applications in targeted drug delivery and molecular imaging.
Main Methods:
- Engineered a self-assembling system using mutated human RNase I fragments (C-tag and Ad-C) forming a disulfide bond.
- Conjugated C-tagged proteins (VEGF, LFn) to Ad-C and assessed their functional activity.
- Modified Ad-C for liposome targeting and developed a labeled probe for imaging.
Main Results:
- The self-assembled
- dock and lock
- system successfully conjugated C-tagged proteins while preserving their function.
- Ad-C modified liposomes enabled targeted delivery of functional proteins.
- A site-specifically modified and labeled Ad-C-VEGF conjugate served as a functional in vivo imaging probe.
Conclusions:
- The developed self-assembling adapter/docking tag system is a promising platform for creating homogeneous and functional protein conjugates.
- This technology facilitates targeted drug delivery and the development of novel molecular imaging agents.
- The system offers new opportunities for utilizing functionally active proteins in biomedical applications.
Related Concept Videos
01:30Assembly of Signaling Complexes
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
00:49Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
01:32Lipids as Anchors
In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
01:45Tail-anchoring of Proteins in the ER Membrane
Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
01:29GPI Anchoring of Proteins in the ER Membrane
GPI-anchoring is a post-translational, reversible protein modification that is ubiquitous in eukaryotes. Such proteins are primarily present on the exoplasmic leaflet of the plasma membrane.
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...